Corticosteroid

EP-104AR, an injectable form of fluticasone propionate designed slowly distribute through the knee joint and provide pain relief for up to 6 months, improved pain vs. a placebo over 12 weeks, according to the manufacturer.

Patients with asthma preferred convenient management options that prioritized decreases in short-term morbidity over long-term goals, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Among patients with pulmonary sarcoidosis, efzofitimod was safe through 24 weeks, and it improved measures of lung function and quality of life when given at a higher dosage, according to study results published in CHEST.

Fewer patients with community-acquired pneumonia using corticosteroids vs. standard care needed mechanical ventilation, but mortality rates did not differ between both groups, according to study results published in CHEST.

Evidence from multiple trials suggests that higher dose corticosteroids “probably” lessen the mortality risk among patients with severe to critical COVID-19, according to study results published in Annals of the American Thoracic Society.

The overall average annual percentage changes in costs for 14 popular rhinology medications outpaced the general annual inflation rate for 5 of 7 years evaluated, according to a study published in Annals of Allergy, Asthma & Immunology.

Perioperative corticosteroids did not improve in-hospital mortality for children who underwent cardiac surgery with cardiopulmonary bypass, though corticosteroids may reduce hospital length of stay, data show.

Following the publication of trial data, corticosteroid administration for patients with severe COVID-19 surged in hospitals, according to study results published in Annals of the American Thoracic Society.

Higher dose corticosteroids heightened the risk for mortality in patients hospitalized with COVID-19 who need oxygen therapy compared with usual care/low dose corticosteroids, according to study results published in The Lancet.

Patients who used a digital-based strategy for evidence-based asthma control experienced modest improvements in medication adherence with lower cost and treatment burdens, according to a study published in The Lancet Respiratory Medicine.